James Vollins files SEC Form 4 disclosures for BIODELIVERY SCIENCES INTERNATIONAL INC. They have made 5 open-market trades across 1 company since 2019, most recently 2022-02-04.
CIK 0001757833
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BDSI | 9,872 | $55K |
Shares reported on the most recent Form 4, priced at the 2022-02-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BDSI | SELL | 2022-02-04 | 2022-02-08 | $3.60 | $133K | +50.3% | +50.5% | N/A |
| BDSI | SELL · 10b5-1 | 2021-02-04 | 2021-02-08 | $4.03 | $49K | +6.8% | -4.0% | -25.2% |
| BDSI | SELL | 2020-12-14 | 2020-12-16 | $4.46 | $224K | -9.9% | -5.1% | -17.0% |
| BDSI | SELL | 2020-05-21 | 2020-05-22 | $4.60 | $199K | -6.1% | -7.1% | +1.7% |
| BDSI | SELL | 2020-03-16 | 2020-03-18 | $3.50 | $13K | +21.5% | +38.4% | +45.9% |
| BDSI | SELL | 2019-11-15 | 2019-11-19 | $6.09 | $363K | +13.1% | +5.9% | -13.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.